452 related articles for article (PubMed ID: 31775739)
1. Tong-Xie-Yao-Fang improves intestinal permeability in diarrhoea-predominant irritable bowel syndrome rats by inhibiting the NF-κB and notch signalling pathways.
Hou Q; Huang Y; Zhu Z; Liao L; Chen X; Han Q; Liu F
BMC Complement Altern Med; 2019 Nov; 19(1):337. PubMed ID: 31775739
[TBL] [Abstract][Full Text] [Related]
2. Tong Xie Yao Fang relieves irritable bowel syndrome in rats via mechanisms involving regulation of 5-hydroxytryptamine and substance P.
Yin Y; Zhong L; Wang JW; Zhao XY; Zhao WJ; Kuang HX
World J Gastroenterol; 2015 Apr; 21(15):4536-46. PubMed ID: 25914462
[TBL] [Abstract][Full Text] [Related]
3. Chang-Kang-Fang alleviates diarrhea predominant irritable bowel syndrome (IBS-D) through inhibiting TLR4/NF-κB/NLRP3 pathway.
Zhang S; Tian D; Xia Z; Yang F; Chen Y; Yao Z; He Y; Miao X; Zhou G; Yao X; Tang J
J Ethnopharmacol; 2024 Aug; 330():118236. PubMed ID: 38670405
[TBL] [Abstract][Full Text] [Related]
4. Effect of Tong Xie Yao Fang on endogenous metabolites in urine of irritable bowel syndrome model rats.
Zhao XY; Wang JW; Yin Y; Li K; Zhang M; Yan FP
World J Gastroenterol; 2019 Sep; 25(34):5134-5151. PubMed ID: 31558862
[TBL] [Abstract][Full Text] [Related]
5. Mucosa repair mechanisms of Tong-Xie-Yao-Fang mediated by CRH-R2 in murine, dextran sulfate sodium-induced colitis.
Gong SS; Fan YH; Wang SY; Han QQ; Lv B; Xu Y; Chen X; He YE
World J Gastroenterol; 2018 Apr; 24(16):1766-1778. PubMed ID: 29713130
[TBL] [Abstract][Full Text] [Related]
6. Tong-Xie-Yao-Fang alleviates diarrhea-predominant irritable bowel syndrome in rats via the GCN2/PERK-eIF2α-ATF4 signaling pathway.
Zhang M; Zheng Y; Li X; Wu H; Liu P; Zhang K; Shi Z; Lv M; Wang F; Tang X
Phytomedicine; 2022 Dec; 107():154350. PubMed ID: 36194974
[TBL] [Abstract][Full Text] [Related]
7. Tong-Xie-Yao-Fang strengthens intestinal feedback control of bile acid synthesis to ameliorate irritable bowel syndrome by enhancing bile salt hydrolase-expressing microbiota.
Jia F; Du L; He J; Zhang Z; Hou X; Dong Q; Bian Z; Zhao L
J Ethnopharmacol; 2024 Sep; 331():118256. PubMed ID: 38677571
[TBL] [Abstract][Full Text] [Related]
8. The Effect of Tong-Xie-Yao-Fang on Intestinal Mucosal Mast Cells in Postinfectious Irritable Bowel Syndrome Rats.
Ma X; Wang X; Kang N; Chen T; Ji H; Lv L; Yin X; Tian Y; Zheng R; Duan Y; Wang F; Tang X
Evid Based Complement Alternat Med; 2017; 2017():9086034. PubMed ID: 28331524
[No Abstract] [Full Text] [Related]
9. Efficacy of Tong-Xie-Yao-Fang granule and its impact on whole transcriptome profiling in diarrhea-predominant irritable bowel syndrome patients: study protocol for a randomized controlled trial.
Wang Y; Huang YQ; Zhu SL; Zhang CR; Chen XL; Hou QK; Liu FB
Trials; 2020 Nov; 21(1):908. PubMed ID: 33143731
[TBL] [Abstract][Full Text] [Related]
10. The Effect and Mechanism of Sancao Lichang Decoction on Diarrhea- Predominant Irritable Bowel Syndrome by Regulating Tlr4/Myd88/Nf-Κb Pathway.
Zhang P; Ma Y; Wang Z; Tang D
Comb Chem High Throughput Screen; 2023; 26(13):2372-2379. PubMed ID: 36856180
[TBL] [Abstract][Full Text] [Related]
11. Momordica charantia polysaccharides alleviate diarrhea-predominant irritable bowel syndrome by regulating intestinal inflammation and barrier via NF-κB pathway.
Ji S; Zhang Q
Allergol Immunopathol (Madr); 2022; 50(3):62-70. PubMed ID: 35527657
[TBL] [Abstract][Full Text] [Related]
12. MiR-144 Increases Intestinal Permeability in IBS-D Rats by Targeting OCLN and ZO1.
Hou Q; Huang Y; Zhu S; Li P; Chen X; Hou Z; Liu F
Cell Physiol Biochem; 2017; 44(6):2256-2268. PubMed ID: 29258088
[TBL] [Abstract][Full Text] [Related]
13. Tong-Xie-Yao-Fang Regulates 5-HT Level in Diarrhea Predominant Irritable Bowel Syndrome Through Gut Microbiota Modulation.
Li J; Cui H; Cai Y; Lin J; Song X; Zhou Z; Xiong W; Zhou H; Bian Y; Wang L
Front Pharmacol; 2018; 9():1110. PubMed ID: 30323765
[TBL] [Abstract][Full Text] [Related]
14. Herbal prescription Chang'an II repairs intestinal mucosal barrier in rats with post-inflammation irritable bowel syndrome.
Wang FY; Su M; Zheng YQ; Wang XG; Kang N; Chen T; Zhu EL; Bian ZX; Tang XD
Acta Pharmacol Sin; 2015 Jun; 36(6):708-15. PubMed ID: 25960135
[TBL] [Abstract][Full Text] [Related]
15. Berberine improves intestinal epithelial tight junctions by upregulating A20 expression in IBS-D mice.
Hou Q; Zhu S; Zhang C; Huang Y; Guo Y; Li P; Chen X; Wen Y; Han Q; Liu F
Biomed Pharmacother; 2019 Oct; 118():109206. PubMed ID: 31306972
[TBL] [Abstract][Full Text] [Related]
16. The inhibitory effect of tongxieyaofang on rats with post infectious irritable bowel syndrome through regulating colonic par-2 receptor.
Hu X; Zhang X; Han B; Bei W
BMC Complement Altern Med; 2013 Oct; 13():246. PubMed ID: 24088410
[TBL] [Abstract][Full Text] [Related]
17. Ginger relieves intestinal hypersensitivity of diarrhea predominant irritable bowel syndrome by inhibiting proinflammatory reaction.
Zhang C; Huang Y; Li P; Chen X; Liu F; Hou Q
BMC Complement Med Ther; 2020 Sep; 20(1):279. PubMed ID: 32928188
[TBL] [Abstract][Full Text] [Related]
18. [Effect of moxibustion on TLR4/MyD88/NF-κB signaling pathway in colon of diarrhea-predo-minant irritable bowel syndrome rats].
Chu HR; Wang Y; Tong L; Wu SB; Wu LB; Li N; Cheng HL
Zhen Ci Yan Jiu; 2020 Aug; 45(8):633-9. PubMed ID: 32869573
[TBL] [Abstract][Full Text] [Related]
19. [Moxibustion relieves colonic inflammation by up-regulating expression of miR-345-3p/miR-216a-5p and down-regulating NF-κB p65 in colonic tissue of rats with diarrhea-predominant irritable bowel syndrome].
Zou L; Ruan JR; Chen JY; Wang JJ; Zhu SS; Liao LM; Li KW; Wang JJ; Chu HR
Zhen Ci Yan Jiu; 2023 Mar; 48(3):226-32. PubMed ID: 36951073
[TBL] [Abstract][Full Text] [Related]
20. Randomised clinical trial: Tong-Xie-Yao-Fang granules versus placebo for patients with diarrhoea-predominant irritable bowel syndrome.
Chen M; Tang TC; Wang Y; Shui J; Xiao XH; Lan X; Yu P; Zhang C; Wang SH; Yao J; Zheng H; Huang DQ
Aliment Pharmacol Ther; 2018 Jul; 48(2):160-168. PubMed ID: 29856472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
